Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18508290 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites
Conditions: Ascites;   Liver Cirrhosis
Intervention: Drug: satavaptan (SR121463B)

Study has passed its completion date and status has not been verified in more than two years.